Fatal interaction between tranylcypromine and imipramine

European Psychiatry

Volumn 18, Issue 5, 2003, Pages 264-265

  Otte, Wim ^a   Birkenhager, Tom K ^b,c   Van den Broek, Walter W ^c  

^a Emergis Centre for Mental Health   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Depression; Imipramine; Serotonin syndrome; Tranylcypromine

Indexed keywords

DANTROLENE; DEXAMETHASONE; IMIPRAMINE; MANNITOL; MIDAZOLAM; PANCURONIUM; TRANYLCYPROMINE;

ACIDOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; DEPRESSION; DISEASE COURSE; DRUG FATALITY; ELECTROENCEPHALOGRAM; HUMAN; HYPERTENSION; HYPERTHERMIA; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; RESPIRATORY ARREST; RIGIDITY; SEROTONIN SYNDROME; SIDE EFFECT; TACHYCARDIA;

EID: 0042973803     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(03)00090-7     Document Type: Article

References (7)

1. Ananth J, Luchins D. A review of combined tricyclic and MAOI therapy. Compr Psychiatry 1977;18:221-30.
2. Berlanga C, Ortega-Soto HA. A 3-year follow-up of a group of treatment depressed patients with a MAOI/tricyclic combination. J Affect Disord 1995;34:187-92.
3. Marley E, Wozniak KM. Clinical and experimental aspects of interactions between amine oxidase inhibitors and amine re-uptake inhibitors. Psychol Med 1983;13:735-49.
4. Nies A, Robinson DS. Monoamine oxidase inhibitors. In: Paykel ES, editor. Handbook of affective disorders. Edinburgh: Churchill Livingstone; 1982. p. 246-61.
5. Sethna ER. A study of refractory cases of depressive illness and their response to combined antidepressant treatment. Br J Psychiatry 1974; 124:265-72.
6. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148: 705-13.
7. White K, Simpson G. Combined MAOI-tricyclic antidepressant treatment: a re-evaluation. J Clin Psychopharmacol 1981;1:264-82.